Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 19 11 2020
accepted: 30 03 2021
entrez: 27 4 2021
pubmed: 28 4 2021
medline: 13 10 2021
Statut: epublish

Résumé

Idiopathic pulmonary fibrosis (IPF) and lung cancer share common risk factors, epigenetic and genetic alterations, the activation of similar signaling pathways and poor survival. The aim of this study was to examine the gene expression profiles of stromal cells from patients with IPF and lung adenocarcinoma (ADC) as well as from normal lung. The gene expression levels of cultured stromal cells derived from non-smoking patients with ADC from the tumor (n = 4) and the corresponding normal lung (n = 4) as well as from patients with IPF (n = 4) were investigated with Affymetrix microarrays. The expression of collagen type IV alpha 1 chain, periostin as well as matrix metalloproteinase-1 and -3 in stromal cells and lung tissues were examined with quantitative real-time reverse transcriptase polymerase chain reaction and immunohistochemistry, respectively. Twenty genes were similarly up- or down-regulated in IPF and ADC compared to control, while most of the altered genes in IPF and ADC were differently expressed, including several extracellular matrix genes. Collagen type IV alpha 1 chain as well as matrix metalloproteinases-1 and -3 were differentially expressed in IPF compared to ADC. Periostin was up-regulated in both IPF and ADC in comparison to control. All studied factors were localized by immunohistochemistry in stromal cells within fibroblast foci in IPF and stroma of ADC. Despite the similarities found in gene expressions of IPF and ADC, several differences were also detected, suggesting that the molecular changes occurring in these two lung illnesses are somewhat different.

Identifiants

pubmed: 33905434
doi: 10.1371/journal.pone.0250109
pii: PONE-D-20-36430
pmc: PMC8078755
doi:

Substances chimiques

Cell Adhesion Molecules 0
Collagen Type IV 0
Extracellular Matrix Proteins 0
POSTN protein, human 0
Matrix Metalloproteinase 3 EC 3.4.24.17
MMP1 protein, human EC 3.4.24.7
Matrix Metalloproteinase 1 EC 3.4.24.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0250109

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: R.K. has received a congress travel stipend from Orion Pharma, a consulting fee from Boehringer-Ingelheim, and lecture fees from Roche and Boehringer-Ingelheim. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6292-7
pubmed: 11983918
Genes Cancer. 2015 Nov;6(11-12):480-9
pubmed: 26807201
Oncogene. 2007 Mar 29;26(14):2082-94
pubmed: 17043657
Mol Med Rep. 2009 Jan-Feb;2(1):73-80
pubmed: 21475793
Respir Res. 2013 Aug 11;14:84
pubmed: 23937155
Cancer. 2003 Jun 1;97(11):2798-805
pubmed: 12767093
Nat Commun. 2020 Apr 21;11(1):1920
pubmed: 32317643
Pathol Res Pract. 2016 May;212(5):357-64
pubmed: 26995105
Eur Respir Rev. 2013 Sep 1;22(129):265-72
pubmed: 23997054
J Thorac Oncol. 2014 May;9(5):664-74
pubmed: 24662457
Pulm Pharmacol Ther. 2017 Aug;45:1-10
pubmed: 28377145
Eur Respir J. 2016 Sep;48(3):889-902
pubmed: 27174888
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626754
Cell Immunol. 2018 Mar;325:1-13
pubmed: 29329637
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7160-5
pubmed: 21474781
Lab Invest. 2012 Sep;92(9):1270-84
pubmed: 22710982
Oncol Lett. 2013 Dec;6(6):1595-1603
pubmed: 24273600
Thorax. 2015 Jan;70(1):48-56
pubmed: 25217476
Jpn J Cancer Res. 2001 Aug;92(8):869-73
pubmed: 11509119
Eur Respir J. 2011 May;37(5):1119-27
pubmed: 21177844
Virchows Arch. 2019 Aug;475(2):181-189
pubmed: 31134329
BMC Pulm Med. 2014 Jul 26;14:120
pubmed: 25064447
PLoS One. 2013;8(4):e59348
pubmed: 23565148
Exp Cell Res. 2010 May 1;316(8):1324-31
pubmed: 20211171
Arthritis Rheum. 2011 Mar;63(3):783-94
pubmed: 21360508
Lab Invest. 2015 Aug;95(8):872-85
pubmed: 26006016
Am J Pathol. 1993 May;142(5):1622-30
pubmed: 8494054
Int J Cancer. 2012 Nov 15;131(10):2264-73
pubmed: 22392539
N Engl J Med. 2014 May 29;370(22):2071-82
pubmed: 24836310
Am J Pathol. 2014 Mar;184(3):859-70
pubmed: 24418260
J Pathol. 2000 Feb;190(2):150-6
pubmed: 10657012
Int J Oncol. 2012 May;40(5):1397-404
pubmed: 22344343
Lancet. 2011 Dec 3;378(9807):1949-61
pubmed: 21719092
BMC Genomics. 2011 Oct 14;12:507
pubmed: 21999641
Am J Physiol Lung Cell Mol Physiol. 2000 Sep;279(3):L562-74
pubmed: 10956632
Respir Res. 2013 Aug 02;14:80
pubmed: 23915349
J Proteome Res. 2017 Aug 4;16(8):3083-3091
pubmed: 28675934
Am J Physiol Lung Cell Mol Physiol. 2012 Dec 15;303(12):L1046-56
pubmed: 23043074
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Am J Pathol. 2011 Oct;179(4):1733-45
pubmed: 21871427
Lancet Oncol. 2014 Feb;15(2):143-55
pubmed: 24411639
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Thorax. 2013 Dec;68(12):1114-21
pubmed: 23783374
Sci Rep. 2018 Mar 5;8(1):3983
pubmed: 29507348
J Pathol. 1997 Jun;182(2):185-91
pubmed: 9274529
Respir Res. 2017 Jan 5;18(1):3
pubmed: 28057004
Am J Respir Crit Care Med. 2009 Jul 15;180(2):167-75
pubmed: 19363140
Am J Respir Cell Mol Biol. 2009 Nov;41(5):583-9
pubmed: 19251946
Eur Respir J. 2010 Mar;35(3):496-504
pubmed: 20190329
Oncol Rep. 2013 Dec;30(6):2617-24
pubmed: 24067943
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
Genomics. 2010 Sep;96(3):134-45
pubmed: 20451601
PLoS Med. 2008 Apr 29;5(4):e93
pubmed: 18447576
Eur Respir Rev. 2019 Sep 11;28(153):
pubmed: 31511255

Auteurs

Mervi Kreus (M)

Research Unit of Internal Medicine, University of Oulu, Oulu, Finland.
Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.

Siri Lehtonen (S)

Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland.

Sini Skarp (S)

Northern Finland Birth Cohorts, Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland.

Riitta Kaarteenaho (R)

Research Unit of Internal Medicine, University of Oulu, Oulu, Finland.
Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH